RO-MTX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO-MTX, covering 2022-05-25 to 2022-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL [Phase 2]